Table 1

Baseline characteristics by study arm of the 58 patients who were randomised and did not withdraw consent*

Variable-median (IQR)Control arm (n=28)PCT-based algorithm arm (n=30)
Age, years54 (46–73)59 (40–67)
Female gender, n (%)9 (32.1%)6 (20%)
Body mass index, kg/m227.6 (22.6–30.9)22.9 (19.5–26.1)
Time to ICU admission, days0 (0–0)0 (0–0)
Time to randomisation, days3 (2–8)3 (2–6)
Location prior to ICU admission, n (%)
 Community14 (50%)22 (73.3%)
 Hospital ward13 (46.4%)8 (26.6%)
 Long-term care facility1 (3.6%)0 (0%)
Type of admission, n (%)
 Surgical1 (3.6%)1 (3.3%)
 Medical27 (96.4%)29 (96.7%)
McCabe class, n (%)
 0: no life-threatening underlying disease18 (69.2%)26 (86.7%)
 1: life expectancy ≤5 years7 (26.9%)4 (13.3%)
 2: life expectancy <1 year1 (3.9%)0 (0%)
Knaus class, n (%)†N=26N=29
 A (%)9 (34.6%)10 (34.5%)
 B (%)3 (11.5%)6 (20.7%)
 C (%)4 (15.4%)3 (10.3%)
 D (%)10 (38.5%)10 (34.5%)
SAPSII score43 (32–52)32.5±27–47
SOFA10 (8–11)9.5 (8.5–11)
Mechanical ventilation, n (%)19 (86%)19 (86%)
Body temperature, °C37.4 (36.7–38.3)37.5 (36.7–38.4)
White cell count, 103/mm313.7 (9.1–17.8)11.4 (7.5–15.2)
PCT, µg/l0.7 (0.4–2.4)1 (0.3–5)
Patients with procalcitonin <0.25 µg/l, n (%)2 (7%)6 (20%)
C reactive protein, mg/l141 (77–220)87 (52–142)
  • *Three patients withdrew consent in the control arm and one in the experimental arm.†Levels of activity limitation are defined as follows: (A) prior good health, no functional limitations; (B) mild to moderate limitation of activity because of chronic medical problem; (C) chronic disease producing serious but not incapacitating restriction of activity and (D) severe restriction of activity due to disease, includes persons bedridden or institutionalised due to illness.

  • ICU, intensive care unit; PCT, procalcitonin; SAPSII, Simplified Acute Physiology Score, 2nd edition; SOFA, Sepsis-related Organ Failure Assessment.